Add
WNI to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| WNI > SEC Filings for WNI > Form 8-K on 4-Jun-2009 | All Recent SEC Filings |
4-Jun-2009
Entry into a Material Definitive Agreement, Financial Statem
On May 29, 2009, Schiff Nutrition Group, Inc., a Utah corporation and wholly-owned subsidiary of the registrant ("SNG"), entered into the Second Amended and Restated License and Product Supply Agreement (the "Amended Agreement") with Unigen Pharmaceuticals, Inc. ("Unigen").
The Amended Agreement provides for SNG's purchase of its requirements of a key ingredient for its joint care products. Unigen has patents and patents pending relating to the key ingredient, and has granted SNG non-exclusive rights to market and sell the ingredient for joint care purposes in certain classes of trade in the United States and certain other countries. Unigen, Inc., a corporation of the Republic of Korea of which Unigen is a wholly-owned subsidiary, provides a guarantee of certain of Unigen's monetary obligations under the Amended Agreement.
The term of the agreement extends to May 28, 2014, with automatic one-year extensions unless terminated by SNG or by Unigen upon SNG's breach of the agreement and failure to cure the breach within a prescribed time period.
The foregoing description of the Amended Agreement is qualified in its entirety by reference to the full text of the Amended Agreement incorporated by reference hereto as Exhibit 10.1.
(d) Exhibits
10.1 Second Amended and Restated License and Product Supply Agreement dated as of May 29, 2009 between Unigen Pharmaceuticals, Inc. and Schiff Nutrition Group, Inc.
|
|